.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Union Health Minister J.P. Nadda recently addressed concerns regarding the India Rabies Vaccine Supply. He confirmed that the nation maintains an adequate inventory of Anti-Rabies Vaccine (ARV) and Rabies Immunoglobulin (RIG). Consequently, current production levels significantly exceed the annual domestic demand for these life-saving treatments.
Minister Nadda highlighted that India possesses an annual production capacity of approximately 8.17 crore vials of ARV. Additionally, manufacturers produce about 1.77 crore vials of RIG each year. However, the annual requirement is considerably lower. Specifically, India records around 58 lakh animal bite cases annually, including 47 lakh dog bites. Therefore, the country maintains a massive surplus and continues to export these vaccines globally.
State governments hold the primary responsibility for distributing vaccines within their regions. Under the National Rabies Control Programme (NRCP), the central government provides necessary technical and financial support. Furthermore, the National Health Mission (NHM) allocates funds to ensure an uninterrupted supply chain. Moreover, a real-time tracking system helps officials monitor stocks effectively across all states. The Ministry also issues regular advisories to prevent any potential local shortages. Because rabies is a fatal virus, the government prioritizes immediate access to post-exposure prophylaxis.
Q1: Is there a shortage of anti-rabies vaccines in India?
No. Union Health Minister J.P. Nadda confirmed that India has a surplus of both ARV and RIG, with production far outstripping domestic needs.
Q2: Who is responsible for vaccine distribution in India?
Health is a state subject. Therefore, individual state and UT governments manage the procurement and distribution of these vaccines using central funds.
Q3: How many animal bite cases are reported in India annually?
India reports approximately 58 lakh animal bite cases per year. Dog bites account for about 47 lakh of these total cases.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
J.P. Nadda confirms India Rabies Vaccine Supply is stable. Annual production of 8.17 crore vials far exceeds the demand from 58 lakh animal bite cases....
4 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
